Literature DB >> 11740877

Risk of laboratory-acquired meningococcal disease.

R Boutet1, J M Stuart, E B Kaczmarski, S J Gray, D M Jones, N Andrews.   

Abstract

Five probable secondary cases of meningococcal disease were identified in microbiology laboratory workers in England and Wales during a 15-year period. All cases had prepared suspensions of Neisseria meningitidis outside a safety cabinet upto seven days before onset of illness. Relative risk in laboratory workers compared with the background adult population was 184 (95% CI 60-431). In view of the potentially serious outcome from this infection, a safety cabinet should always be used when preparing or working with suspensions of meningococci. Vaccination policy for microbiology laboratory workers should be reviewed. Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2001        PMID: 11740877     DOI: 10.1053/jhin.2001.1084

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  11 in total

Review 1.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 2.  Assessing the risk of laboratory-acquired meningococcal disease.

Authors:  James J Sejvar; David Johnson; Tanja Popovic; J Michael Miller; Frances Downes; Patricia Somsel; Robbin Weyant; David S Stephens; Bradley A Perkins; Nancy E Rosenstein
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Risk and prevention of meningococcal disease among education workers: A review.

Authors:  Philippe De Wals; Pierre Deshaies; Gaston De Serres; Bernard Duval; Lise Goulet; Bernard Pouliot; Sylvie Ricard; Maurice Poulin
Journal:  Can J Infect Dis       Date:  2004-03

4.  Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002.

Authors:  M F Howitz; S Samuelsson; K Mølbak
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

Review 5.  Autopsy Biosafety: Recommendations for Prevention of Meningococcal Disease.

Authors:  Erin G Brooks; Suzanne R Utley-Bobak
Journal:  Acad Forensic Pathol       Date:  2018-06-06

6.  Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage.

Authors:  Hélène Omer; Graham Rose; Keith A Jolley; Eric Frapy; Jean-Ralph Zahar; Martin C J Maiden; Stephen D Bentley; Colin R Tinsley; Xavier Nassif; Emmanuelle Bille
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

Review 7.  Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

Authors:  Ana Cláudia Coelho; Juan García Díez
Journal:  Front Bioeng Biotechnol       Date:  2015-04-28

8.  Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine.

Authors:  Eva Hong; Aude Terrade; Muhamed-Kheir Taha
Journal:  Hum Vaccin Immunother       Date:  2016-11-03       Impact factor: 3.452

9.  Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine.

Authors:  Johannes Elias; Jamie Findlow; Ray Borrow; Angelika Tremmel; Matthias Frosch; Ulrich Vogel
Journal:  J Occup Med Toxicol       Date:  2013-03-04       Impact factor: 2.646

10.  Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine.

Authors:  Jamie Findlow; Helen Findlow; Sarah Frankland; Ann Holland; Daniel Holme; Emma Newton; Jo Southern; Pauline Waight; Ed Kaczmarski; Elizabeth Miller; Ray Borrow
Journal:  J Occup Med Toxicol       Date:  2014-07-16       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.